Andrea obtained her MD at the University of Munich. After her post-doc at the University of Bonn, she joined EPFL as an assistant professor in 2014, where she became Full Professor in 2021. Her research focuses on mechanisms of innate immunity. She played a major role in deciphering how cells respond to intracellular DNA as a signal of infection via the so-called cGAS-STING pathway – a fundamental discovery, which paved the way for promising new immunotherapies. Amongst several distinctions, Andrea Ablasser is recipient of the EMBO Gold Medal, the Dr. Josef Steiner Cancer Award, the Coley Award, the Sanofi-Institut Pasteur Award, the National Latsis Prize, the ACTERIA Prize, and the Eppendorf Award, and she is an elected member of EMBO and Leopoldina. She has been nominated “Highly Cited Researcher”. She is the founding scientist of IFM Due, a biopharmaceutical company developing cGAS-STING antagonists for the treatment of inflammatory disorders.